The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have released a new standard/guideline for estrogen receptor imaging in breast cancer patients using FES PET. This standard is designed to help physicians recommend, perform, interpret, and report 18F-FES PET studies for patients with breast cancer. The guideline emphasizes the importance of the ER in breast cancer and outlines the benefits of 18F-FES PET in assessing ER expression and predicting response to therapy. It also includes information on clinical indications, patient selection, imaging procedures, and standardized quality control measures for 18F-FES PET. The publication of these standards is part of the SNMMI/EANM’s effort to advance the science of nuclear medicine and improve patient care.
Source link
New guidelines for imaging estrogen receptor in breast cancer patients using FES PET
